INTRODUCTION
Alterations of the p53 tumor suppressor gene are correlated with a critical step in the development of many human cancers. The tumor suppressor gene functions include regulation of the cell cycle and the cellular response to DNA damage, initiation of DNA repair and replication, induction of apoptosis and promotion of cell differentiation. Inactivation of p53 may result from a number of events including mutation of the p53 gene, binding of p53 to cellular or viral proteins and cytoplasm sequestration of the protein. 1 In cervical carcinoma, loss of p53 function can occur through its interaction with the E6 protein of oncogenic HPV types. In addition, DNA of these HPV types is often found integrated into cellular DNA. This integration can result in deletion or mutation of some viral genes. 2 The clinical significance of p53 changes has been evaluated elsewhere for a wide variety of human cancers, including cervical cancer.
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Although cervical low-grade neoplasia can progress to cervical cancer, few molecular studies have indicated p53 mutation at this stage of the lesion.
In the present study, we investigate possible mutations in the region of exons 5-8 of the p53 gene and HPV infection in women who underwent routine Papanicolaou testing. HPV DNA was detected by using the MY09/11 consensus primer, which amplifies 460 bp DNA sequences within the L1 region. β-globin primers (0.1 pmol each), which amplify a 280 bp region of human DNA, were used as internal controls. HPV typing was done by PCR amplification with primers from the E6 gene DNA sequences of HPV 6, 11, 16, 18, 31, 33, and 35. PCR products were analyzed on 1.3% agar gel with ethidium bromide staining. 2 PCR amplification of p53 exons 5 to 8 was carried out for SSCP analysis as previously described by Pinheiro et al. (1999) .
RESULTS
The results are summarized in the Table.  Abnormal as squamous neoplasia was negative to L1 HPV primers, but it was positive to HPV 16 and 18 E6 gene. The CIN III case was also infected with both HPV 16 and 18.
We found HPV type 6 (low risk) in the CIN III lesion of an HIV seropositive woman. The patient was negative for the oncogenic HPV types analyzed in this paper.
DISCUSSION
The status of the p53 gene and HPV infection were analyzed in ten cervical lesions. Point mutations were detected in two patients with premalignant and malignant lesion, respectively, by PCR/SSCP. No p53 mutation was found in benign lesions, in agreement with the literature 3 . The PCR/SSCP method has high sensitivity and specificity for the detection of mutations comparable to DNA sequencing. 4 P53 alterations are not frequent in cervical cancer, being generally detected in negative HPV tumors. 5 However, we found two cases simultaneously positive for p53 mutation and high-risk HPV infection. One of the patients presented an invasive carcinoma and the other presented CIN III. Although other authors have reported p53 mutation as occurring only in a late stage of this disease, 3 it is worth noting that we found a p53 mutation in one premalignant case, suggesting that it may have occurred early and thus may contribute to the process of cancer establishment.
We detected HPV in eight of the ten cases by using two sets of HPV primers. Differences in HPV positivity were found in squamous carcinoma, negative to L1 gene but positive for type-specific primers. Monk et al. 6 have already described the same findings. We suggest that the L1 gene may have been deleted during the integration of HPV DNA. Hence, the use of two sets of primers may increase HPV detection in cervical tumors, elucidating the etiology of these cancers.
In conclusion, although we only studied a small number of cervical lesions, we have shown that p53 mutations and oncogenic HPV infection are not mutually exclusive events and thus may cooperate in the establishment of malignant cells. tumor p53 estão associadas a uma fase crítica no desenvolvimento de muitos canceres humanos. As funções desse gene incluem a regulação do ciclo celular e da resposta a danos no DNA, iniciação do reparo e da replicação do DNA, indução da apoptose e promoção da diferenciação celular. A inativação da p53 é o resultado de vários eventos incluindo mutações no gene p53 (com ou sem deleções alélicas associadas), ligação da p53 a proteínas virais ou celulares, e apreensão citoplasmática da proteína. RELATO DE CASO: Esfregaços de 10 pacientes 
